Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pitavastatin/Ezetimibe in Hypercholesterolemia with Elevated Triglycerides
NCT07442630Phase 4Active, not recruiting
- Sponsor
- JW Pharmaceutical Corporation
- Start
- Aug 2023
- Primary completion
- Jan 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of ezetimibe in hypercholesterolemia, sponsored by JW Pharmaceutical Corporation. Started Aug 2023; status: active, not recruiting.
02
Drugs
ezetimibe
03
Conditions
hypercholesterolemia
Beyond the preview
Go deeper on NCT07442630.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07442630.